Merit Medical Systems (MMSI)

Healthcare · Medical Instruments & Supplies
$87.21 +2.30% on the day Market cap $5.3B 52-week range $59.74 to $94.75 Prices as of Oct 11, 2026

What the price implies

A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.

Free cash flow growth the price needs
8% a year for 10 years

At a market value of $5.3B, Merit Medical Systems's free cash flow of $216M (fiscal 2025) would need to grow about 8% a year for the stock to be worth today's price. That is slower than the company has grown its free cash flow over the last 9 years.

Assumes a 9% discount rate and 3% growth after year 10, on free cash flow (operating cash flow minus capital spending) from Merit Medical Systems's SEC filings. Change any assumption, or model revenue and margins instead, in the Modeling tab, or try your own numbers in the reverse DCF calculator.

Implied by the price7.7% a year
Free cash flow, last 9 years29.7% a year
Revenue, same period10.8% a year
Price to free cash flow24.6x

Fundamental grade

C

Five factors scored 1 to 9 from MMSI's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.

Valuation5
Profitability5
Growth6
Financial health7
Cash efficiency7

Results from SEC filings

Fiscal years, from Merit Medical Systems's 10-K filings. Ten years of the full income statement, balance sheet and cash flow.

Fiscal year20212022202320242025
Revenue$1.1B$1.2B$1.3B$1.4B$1.5B
Net income$48M$75M$94M$120M$128M
Free cash flow$119M$69M$111M$186M$216M
EPS (diluted)$0.84$1.29$1.62$2.03$2.13
Operating margin5.7%7.6%9.9%11.5%12.2%

Where the revenue comes from

Revenue by segments, fiscal 2025. Every breakdown, year by year.

Cardiovascular$1.4B95%
Endoscopy$73M5%

Superinvestors who own MMSI

From each investor's latest 13F filing (what a 13F shows). 2 of the investors we track hold it.

InvestorLast quarterValue% of portfolioQuarter
Lee Ainslie
Maverick Capital
Added $68M0.60%Q2 2026
Cliff Asness
AQR Capital Management
Added $32M0.01%Q2 2026

Insider buying

Open-market purchases by Merit Medical Systems's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.

No open-market insider purchases of MMSI in the last 12 months. Most insider activity is selling and option exercises, which aren't shown here.

Get an alert at your buy price

Pick the price you'd be interested at. We'll email you when MMSI trades at or below it.

$

New accounts get 7 days of Pro, price alerts included. No card needed.

In the full deep dive

DCF fair value per share
Yearly return (IRR) at today's price
Growth implied by revenue and margins
15+ years of statements and quarters

Questions

What growth does Merit Medical Systems's stock price imply?

At a market value of $5.3B, Merit Medical Systems would need its free cash flow to grow about 8% a year for 10 years (discounted at 9%, 3% growth after that) to be worth today's price. Over the last 9 years its free cash flow grew 30% a year.

Are Merit Medical Systems insiders buying the stock?

No open-market insider purchases of MMSI in the last 12 months, according to SEC Form 4 filings.

Which superinvestors own Merit Medical Systems?

2 of the superinvestors Investingly tracks hold MMSI in their latest 13F, including Lee Ainslie, Cliff Asness.

Prices and ratios as of Oct 11, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.